Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 463 entries
View as:

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase: N/A Priority: Normal
NCT ID: NCT02283424 Org: User:
Start: 10/31/14 End: 12/31/17 Due: 12/31/18

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05631886 Org: User:
Start: 07/04/23 End: 12/30/26 Due: 12/30/27

Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

Phase: N/A Priority: Normal
NCT ID: NCT02360956 Org: User:
Start: 12/31/14 End: 06/30/16 Due: 06/30/17

Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01267331 Org: User:
Start: 12/31/10 End: 06/30/13 Due: 06/30/14

China-Administration of Nicorandil Group（CHANGE）

Phase: N/A Priority: Normal
NCT ID: NCT03445728 Org: User:
Start: 02/24/18 End: 10/01/21 Due: 10/01/22

Postoperative Anxiety and Depression Among Older Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT06495840 Org: User:
Start: 04/01/20 End: 04/30/22 Due: 04/30/23

Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT05888909 Org: User:
Start: 08/01/22 End: 12/31/26 Due: 12/31/27

Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04182724 Org: User:
Start: 11/12/19 End: 05/12/22 Due: 05/12/23

Clinical Frailty Assessment and Postoperative Adverse Outcomes and Quality of Life in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT05387850 Org: User:
Start: 09/20/20 End: 01/30/22 Due: 01/30/23

SVV and PPV Predict Fluid Responsiveness in Mechanically Ventilated Elderly Patients Under General Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT04388995 Org: User:
Start: 05/12/20 End: 08/31/20 Due: 08/31/21

Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model

Phase: N/A Priority: Normal
NCT ID: NCT03936504 Org: User:
Start: 10/17/19 End: 10/30/21 Due: 10/30/22

Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT02489240 Org: User:
Start: 07/31/15 End: 07/31/17 Due: 07/31/18

Transversus Abdominis Plane Block on Postoperative Analgesic Efficacy in Elderly Patients Undergoing Minimally Invasive Gastrointestinal Tumor Surgery

Phase: N/A Priority: Normal
NCT ID: NCT07013721 Org: User:
Start: 06/02/25 End: 04/15/26 Due: 04/15/27

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT06883149 Org: User:
Start: 03/19/25 End: 12/01/30 Due: 12/01/31

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06641453 Org: User:
Start: 11/15/24 End: 11/15/28 Due: 11/15/29

Predictive Ability of Different Frailty Indices for Postoperative Infections in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT06985771 Org: User:
Start: 03/01/25 End: 05/06/25 Due: 05/06/26

Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules

Phase: N/A Priority: Normal
NCT ID: NCT06733753 Org: User:
Start: 12/09/24 End: 12/31/30 Due: 12/31/31

Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)

Phase: N/A Priority: Normal
NCT ID: NCT03208335 Org: User:
Start: 01/01/17 End: 12/31/19 Due: 12/31/20

A Comparative Study of Two Kinds of Hemodialysis Filters

Phase: N/A Priority: Normal
NCT ID: NCT05899283 Org: User:
Start: 03/01/21 End: 10/30/22 Due: 10/30/23

Central Obesity and Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03082378 Org: User:
Start: 03/01/17 End: 12/31/19 Due: 12/31/20

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04976218 Org: User:
Start: 03/15/22 End: 12/31/24 Due: 12/31/25

Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02372708 Org: User:
Start: 08/31/08 End: 05/31/14 Due: 05/31/15

Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT03129594 Org: User:
Start: 02/28/13 End: 02/28/15 Due: 02/28/16

Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han Population

Phase: N/A Priority: Normal
NCT ID: NCT01504243 Org: User:
Start: 05/31/10 End: 05/31/12 Due: 05/31/13

Endoscopic Submucosal Dissection for Gastrointestinal Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT01378507 Org: User:
Start: 01/31/09 End: 04/30/13 Due: 04/30/14